Axsome Therapeutics (AXSM) Interest & Investment Income (2015 - 2026)
Axsome Therapeutics (AXSM) reported Interest & Investment Income of -$1.2 million for Q1 2026, up 51.25% on a YoY basis from -$783447.1 in Q1 2025, and down 1.11% sequentially from -$1.2 million in Q4 2025.
Axsome Therapeutics (AXSM) Interest & Investment Income (2015 - 2026) Analysis & Trends
Axsome Therapeutics (AXSM) has 12 years of Interest & Investment Income data on file, last reported at -$1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 51.25% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$5.3 million (up 32.92% YoY), and the FY2025 full-year result was -$6.6 million, changed 0.18% from the prior year.
- Interest & Investment Income retreated to -$1.2 million in Q1 2026, from -$1.2 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of -$702000.0 in Q4 2023 to a low of -$2.7 million in Q2 2023.
- A 5-year average of -$1.7 million and a median of -$1.3 million in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 68.6% in 2023 and sank 214.81% in 2024, its largest moves.
- Tracing AXSM's Interest & Investment Income over 5 years: stood at -$1.3 million in 2022, then jumped by 46.94% to -$702000.0 in 2023, then slumped by 214.81% to -$2.2 million in 2024, then soared by 46.97% to -$1.2 million in 2025, then fell by 1.11% to -$1.2 million in 2026.
- Business Quant data shows AXSM's Interest & Investment Income at -$1.2 million in Q1 2026, -$1.2 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Axsome Therapeutics | 12.28 Bn | 11.98 Bn | 176.48 Mn | -1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.19 Mn |
| Dec 31, 2025 | -1.17 Mn |
| Sep 30, 2025 | -1.12 Mn |
| Jun 30, 2025 | -1.83 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Dec 31, 2024 | -2.21 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | -1.30 Mn |
| Mar 31, 2024 | -1.08 Mn |
| Dec 31, 2023 | -702,000.00 |
| Sep 30, 2023 | -757,000.00 |
| Jun 30, 2023 | -2.73 Mn |
| Mar 31, 2023 | -2.26 Mn |
| Dec 31, 2022 | -1.32 Mn |
| Sep 30, 2022 | -2.41 Mn |
| Jun 30, 2022 | -2.26 Mn |
| Mar 31, 2022 | -1.34 Mn |
| Dec 31, 2021 | -1.37 Mn |
| Sep 30, 2021 | -1.48 Mn |
| Jun 30, 2021 | -1.44 Mn |